These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19733011)

  • 21. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
    Coles M; Bicknell W; Watson AA; Fairlie DP; Craik DJ
    Biochemistry; 1998 Aug; 37(31):11064-77. PubMed ID: 9693002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
    White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
    Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Directing the secondary structure of polypeptides at will: from helices to amyloids and back again?
    Pagel K; Vagt T; Koksch B
    Org Biomol Chem; 2005 Nov; 3(21):3843-50. PubMed ID: 16239998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biology of amyloid: structure, function, and regulation.
    Greenwald J; Riek R
    Structure; 2010 Oct; 18(10):1244-60. PubMed ID: 20947013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Formation and participation of nano-amyloids in pathogenesis of Alzheimer's disease and other amyloidogenic diseases].
    Mal'tsev AV; Galzitskaia OV
    Biomed Khim; 2010; 56(6):624-38. PubMed ID: 21395066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational preferences of non-polar amino acid residues: an additional factor in amyloid formation.
    Johansson J; Nerelius C; Willander H; Presto J
    Biochem Biophys Res Commun; 2010 Nov; 402(3):515-8. PubMed ID: 20971069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a possible amyloidogenic precursor in glutamine-repeat neurodegenerative diseases.
    Armen RS; Bernard BM; Day R; Alonso DO; Daggett V
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13433-8. PubMed ID: 16157882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of tau in the polymerization of peptides from beta-amyloid precursor protein.
    Caputo CB; Sygowski LA; Scott CW; Sobel IR
    Brain Res; 1992 Dec; 597(2):227-32. PubMed ID: 1472995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane pores in the pathogenesis of neurodegenerative disease.
    Kagan BL
    Prog Mol Biol Transl Sci; 2012; 107():295-325. PubMed ID: 22482454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid Structural Changes Studied by Infrared Microspectroscopy in Bigenic Cellular Models of Alzheimer's Disease.
    Paulus A; Engdahl A; Yang Y; Boza-Serrano A; Bachiller S; Torres-Garcia L; Svanbergsson A; Garcia MG; Gouras GK; Li JY; Deierborg T; Klementieva O
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copper reduction by copper binding proteins and its relation to neurodegenerative diseases.
    Opazo C; Barría MI; Ruiz FH; Inestrosa NC
    Biometals; 2003 Mar; 16(1):91-8. PubMed ID: 12572668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing the pressure-temperature stability of amyloid fibrils provides new insights into their molecular properties.
    Meersman F; Dobson CM
    Biochim Biophys Acta; 2006 Mar; 1764(3):452-60. PubMed ID: 16337233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid and Alzheimer's disease.
    Lei H
    Protein Cell; 2010 Apr; 1(4):312-314. PubMed ID: 21203942
    [No Abstract]   [Full Text] [Related]  

  • 36. Radical changes in beta-amyloid form and function.
    Vitek MP
    Mol Chem Neuropathol; 1996; 28(1-3):49-55. PubMed ID: 8871941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vortex-induced chiral bifurcation in aggregating insulin.
    Dzwolak W
    Chirality; 2010; 22 Suppl 1():E154-60. PubMed ID: 20845432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Key Alzheimer's findings questioned.
    Ledford H
    Nature; 2010 Aug; 466(7310):1031. PubMed ID: 20739979
    [No Abstract]   [Full Text] [Related]  

  • 39. Thousands of amyloids may foil Alzheimer's drugs.
    Hodgson J
    Nat Biotechnol; 2019 Feb; 37(2):114-115. PubMed ID: 30718876
    [No Abstract]   [Full Text] [Related]  

  • 40. Determining the Protein Stability of Alzheimer's Disease Protein, Amyloid Precursor Protein.
    Delport A; Hewer R
    Protein J; 2019 Aug; 38(4):419-424. PubMed ID: 30937647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.